Real-world outcomes of addition of insulin glargine 300 U/mL (Gla-300) to glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in people with type 2 diabetes: The DELIVER-G study
在 2 型糖尿病患者中，将甘精胰岛素 300 U/mL (Gla-300) 添加到胰高血糖素样肽-1 受体激动剂 (GLP-1 RA) 治疗方案中的真实世界结果：DELIVER-G 研究
期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14739
Bailey, Timothy S; Gill, Jasvinder; Jones S, Merwyn; Shenoy, Laxmi; Nicholls, Charlie; Westerbacka, Jukka
